ARM (ARM.O) released its FY2027 Q1 results (quarter ended Jun 2026) after the U.S. close on the morning of Jul 30 Beijing time. Key takeaways are as follows:

1) Headline numbers: Revenue came in at $1.29bn (+22% YoY), in line with consensus ($1.26bn), driven by growth in both License and Royalty. GPM was 97.2%, remaining at an elevated level.

2) Business mix: License and Royalty were roughly 1:1. Each stream accounted for about half of total revenue.

a) License revenue was $570mn, up 23% YoY, broadly consistent with the company's full-year growth guide (~20%).

b) Royalty revenue was $720mn, up 22% YoY, mainly on stronger data center–related demand. Data center demand was the primary driver.

With ARM-architecture server CPUs ramping at major hyperscalers and HPC vendors, data center Royalty more than doubled YoY this quarter. Momentum remained strong.

3) Core metrics: (i) Annual Contract Value (ACV): $Arm(ARM.US) posted ACV of $1.73bn, up 4.3% QoQ. We estimate new contracts added approx. $280mn of revenue this quarter. (ii) Remaining Performance Obligations (RPO): the company stopped disclosing this metric starting this quarter.

4) Opex: R&D expense was $840mn, up 29% YoY. The continued increase reflects heavier investment in next-gen architectures, compute subsystems, and the AGI CPU product line to address more complex compute scenarios.

With R&D and SG&A both trending higher, core OPM retreated to around 7% this quarter. The total opex ratio reached roughly 90%.

5) Next-quarter guidance: ARM guides FY2027 Q2 revenue of $1.33–1.43bn (midpoint $1.38bn, +21.6% YoY), in line with consensus ($1.35bn). Non-GAAP EPS is guided at $0.43–0.51, also in line with market expectations ($0.45).

Dolphin Research View: a 'muted' print that does not support the 'high multiple' case

ARM's quarter was underwhelming. Versus its consistently high GPM (97%+), the revenue trajectory and opex profile matter more.

Revenue grew 22% YoY this quarter, essentially in line and fairly muted, meeting market expectations. Notably, R&D and SG&A rose sharply, pushing the opex ratio to about 90%. In short, even with a 97.2% GPM, core OPM was only around 7%.

Beyond the print, investors focused on three items: guidance, ACV, and RPO. These are the key metrics to watch.

1) Guidance: the company guides next-quarter revenue at $1.33–1.43bn, in line with consensus ($1.35bn). License is expected to grow ~30% YoY, while Royalty growth should slow to around 13%.

Hurt by higher handset memory prices, ARM cut FY2027 Royalty growth to ~18% (from 20%). Upside in License should offset Royalty softness, keeping the full-year growth pace unchanged.

2) ACV as a forward indicator: ACV was $1.73bn, up 4.3% QoQ. Based on this quarter's revenue mix, Dolphin estimates roughly $415mn was recognized from prior contracts, while 'new contracts recognized this quarter + Royalty' totaled about $870mn. This helps bridge ACV to reported revenue.

As for RPO, the company has stopped disclosing it starting this quarter. It will not be reported going forward.

Within ARM's legacy businesses, the AI boom has created both tailwinds and headwinds. The net impact is mixed.

On one hand, adoption of ARM in compute has risen sharply, allowing ARM to benefit directly from the AI cycle. On the other, AI-driven memory price inflation pressures handset and PC OEMs, leading ARM to lower its full-year Royalty guide.

Beyond legacy, ARM aims to directly enter the data center CPU market to unlock a larger growth runway. Its first product launched in Mar and has shipped to multiple customers, with a second-gen ARM AGI CPU planned for 2027.

Management says demand exceeds $2bn (unchanged), and ARM has secured $1bn of manufacturing capacity for FY2027–FY2028. This anchors initial supply for the ramp.

At the current market cap of $240.1bn, ARM trades at roughly 100x on FY2027 post-tax core operating profit (Non-GAAP), assuming +23% revenue growth, 97.4% GPM, and a 9% tax rate. In a fragile AI tape, multiple compression is more pronounced for high-valuation names.

With only 20%+ growth, a triple-digit PE rests on confidence in sustained high growth to absorb the multiple. Given the fragile AI backdrop and a cut to the full-year Royalty guide, investors may question the durability of that growth.

ARM's CPU business has not yet contributed revenue and is expected to show material contribution starting in FY2027 Q3. The first product's GPM is only 35%–45% while the opex ratio is ~90%, implying the CPU business will be loss-making in its initial phase.

Overall, in a choppy market, ARM's 'high multiple' needs 'outsized execution' to support it. This print was merely 'in line', included a cut to parts of the full-year guide, and did not lift the CPU demand outlook, which is likely to disappoint.

MSFT stopped raising capex and was 'rewarded' by the market. This could act like a domino effect: if more tech giants turn cautious on spend, it will directly hit growth across the AI supply chain. As focus shifts from 'growth' to 'visibility', high-multiple ARM may struggle to stay in favor.

Below are Dolphin Research's charts on ARM's results and related data. For reference.

<End of full text>

Dolphin Research on ARM

May 7, 2026 Trans: Arm (Trans): AI CPU to start generating revenue by end of next fiscal year; long-term targets unchanged

May 7, 2026 Earnings Take: ARM: 'Short-term volatility' masks its edge; will AI premium anchor a 'long-term re-rating'?

Feb 5, 2026 Trans: Arm (Trans): Limited impact from smartphones; FY2027 to maintain 20% growth

Feb 5, 2026 Earnings Take: ARM: AI tailwinds intact, but smartphones are a current drag

Nov 6, 2025 Trans: ARM (Trans): All incremental compute is based on Arm architecture

Nov 6, 2025 Earnings Take: ARM: Backed by SoftBank, a 'must-have' on the AI chain?

Jul 31, 2025 Trans: ARM (Trans): Evaluating the feasibility of entering 'physical chips'

Jul 31, 2025 Earnings Take: ARM: The 'chip tax' props up results, but orders are 'chilly' amid heavy spending

May 8, 2025 Trans: ARM (Trans): Tariffs have no direct impact

May 8, 2025 Earnings Take: ARM: Guidance 'cold shower' warns of risks; is the valuation bubble at risk?

Feb 6, 2025 Trans: ARM (Trans): Watch the growth of 'taxation' power

Feb 6, 2025 Earnings Take: ARM: AI helps deliver, but a 'high multiple' remains a 'sweet burden'

Risk Disclosure and Disclaimer: Dolphin Research Disclaimer and General Disclosure